J&J Win Highlights FDA's Impact On Hip Implant Cases

Law360, New York (April 18, 2013, 7:52 PM EDT) -- After a costly loss in its first trial, Johnson & Johnson subsidiary DePuy Inc. this week managed to even its record in metal-on-metal implant cases, and attorneys say a crucial difference was the company's ability to tell jurors that the U.S. Food and Drug Administration had cleared the device.

A state court jury in Chicago on Tuesday handed down a verdict in favor of DePuy, rejecting the plaintiff's request for $5 million in compensatory damages for injuries allegedly caused by her ASR XL hip implant....
To view the full article, register now.